SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001829126-20-000203
Filing Date
2020-11-27
Accepted
2020-11-27 15:25:22
Documents
3
Period of Report
2020-11-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K inspyrtherapeutics_8k.htm 8-K 33043
2 EXHIBIT 3.01(I) inspyrtherapeutics_ex3-01i.htm EX-3.01(I) 8942
3 EXHIBIT 10.01 inspyrtherapeutics_ex10-01.htm EX-10.01 14552
  Complete submission text file 0001829126-20-000203.txt   57842
Mailing Address 2629 TOWNSGATE RD, SUITE 215 WESTLAKE VILLAGE CA 91361
Business Address 2629 TOWNSGATE RD, SUITE 215 WESTLAKE VILLAGE CA 91361 (210) 479-8112
Inspyr Therapeutics, Inc. (Filer) CIK: 0001421204 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55331 | Film No.: 201354964
SIC: 2834 Pharmaceutical Preparations